Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinoma-Reference-Cited by-同舟云学术

Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinoma

Published:2021-01 Issue:1 Volume:39 Page:75.e1-75.e8
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Li Xu,Li Siming,Chi Zhihong,Cui Chuanliang,Si Lu,Yan Xieqiao,Mao Lili,Lian Bin,Tang Bixia,Wang Xuan,Bai Xue,Zhou Li,Kong Yan,Dai Jie,Guo Jun,Sheng Xinan

Funder

National Natural Science Foundation of China

Beijing Municipal Science and Technology Commission

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update;Roupret;Eur Urol,2011

2. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987;Bellmunt;J Clin Oncol,2012

3. Behavior of urothelial carcinoma with respect to anatomical location;Catto;J Urol,2007

4. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract;Langner;Virchows Arch,2006

5. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature;Lughezzani;Eur Urol,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients;European Urology Oncology;2024-07

2. Efficacy of cytoreductive surgery for metastatic upper tract urothelial carcinoma: a Surveillance, Epidemiology and End Results (SEER) study of 508 patients;Translational Andrology and Urology;2024-06

3. Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis;Critical Reviews in Oncology/Hematology;2024-04

4. Safety and efficacy of radiotherapy combined with chemotherapy for recurrent metastatic renal pelvic and ureteral carcinoma;World Journal of Urology;2024-01-10

5. Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials;Journal of Clinical Oncology;2023-11-21